Heather Bodenstab, PharmD
Disclosures: Nothing to disclose
HEATHER MAUREEN MONK, PHARM D

 

HEATHER MONK BODENSTAB, PHARM.D.

The Children’s Hospital of Philadelphia

Department of Pharmacy

34th Street and Civic Center Boulevard

Philadelphia, PA 19104

Office: (215) 590-2133                                         

Fax: (215) 590-1901

 

535 W. Hortter Street

Philadelphia, PA 19119

(267)-761-1617 [voice mail]

bodenstabh@email.chop.edu

 

 

 

Updated 10/2017

 

Education and post doctoral experience

 

 

Pediatric Specialty Residency

ASHP-Accredited

The Children’s Hospital of Philadelphia

 

July 2008 – June 2009

Pharmacy Practice Residency

ASHP-Accredited

The Children’s Hospital of Philadelphia

July 2007 – June 2008

Doctor of Pharmacy
Cum Laude

West Virginia University
Morgantown, WV

Graduation May 2006

licensure / Certification / training

 

 

Basic Life Support and Pediatric Advanced Life Support Certification

 

Residency Learning System (RLS) Training

 

Pennsylvania State Board of Pharmacy

License #RP440984

 

 

April 2017

 

May 2011

 

June 2006 - Present

 

 

professional experience

 

The Children’s Hospital of Philadelphia

Philadelphia, PA

Clinical Pharmacist,  Newborn/Infant Intensive Care Unit

Clinical Pharmacist,  Center for Bone Health

July 2009 – Present

 

 

The Children’s Hospital of Philadelphia
Philadelphia, PA

Staff Pharmacist

June 2006 – July 2007

 

teaching experience

 

 

Thomas Jefferson University

Philadelphia, PA

Adjunct Instructor, Jefferson School of Pharmacy

Vaccinations

Neonatology

Gastrointestinal Diseases

Pediatric Seizure Disorders

 

University of Charleston

Charleston, WV

Adjunct Instructor, Robert C. Byrd School of Pharmacy

 

August 2010 – Present

 

 

 

 

 

 

 

August 2009 – Present

 

             Neonatology

             Cystic Fibrosis

             Sickle Cell Disease

            Pediatric Pharmacology

 

University of Pennsylvania

Philadelphia, PA

Guest Lecturer, Pediatric Pharmacology and Therapeutics in Nursing Practice, School of Nursing

 

 

 

 

 

April 2009 – Present

 

             Neonatology

             Pediatric Bone Diseases

             Gastroenterology

 

Wilkes University

Wilkes-Barre, PA

Adjunct Instructor, Nesbitt School of Pharmacy

 

 

 

 

August 2008 - Present

 

                Vaccinations

                Neonatology

                Pediatric Seizure Disorders

                Gastroenterology

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Committees

 

NICU Vaccine Committee, Member

NICU Sepsis Committee, Member

NICU Chronic Lung Disease Team, Member

NICU Codes Committee, Member

NICU Peri-Operative Committee, Member

NICU ECMO Commitee, Member

NICU Continuous Quality Improvement, Participant

2015—Present

2014—Present

2012—Present

2009—Present

2009 – Present

2009 – Present

2009 – Present

 

NICU Steering, Member

2009 – Present

 

NICU Medication Management and Information Technology, Co-Chair

2009 – Present

 

NICU Bone Health, Member

2008 – Present

 

Bone Health Collaborators, Member

2008 – Present

 

NICU Nutrition Continuous Quality Improvement, Member

2008 – Present

 

Therapeutic Standards Committee

Drug Use Evaluation Committee

Adverse Drug Reaction Committee

Formulary Committee

2008 – Present

2008 – Present

2008 – Present

              2008 – Present

 

Clinical Pathway Team

NICU Vaccination and Immunization Improvement

NICU Sepsis

Necrotizing Enterocolitis

Emergency Department Status Epilepticus

Neonatal Abstinence Syndrome

Post-Operative Thyroidectomy Management of Hypocalcemia

Post-Operative Pain Management in the Neonate

Sedation/Analgesia Management of the Mechanically Ventilated Neonate

Hyperinsulinemia Management

CT/MRI Sedation in the Neonate

ECMO Anticoagulation

ECMO Sedation

NICU Acute Intratracheal Obstruction

Myelomeningocele Peri-operative

NICU Micrognathia and Mandibular Distractors

Neonatal Seizures

NICU Unplanned Extubation

       NICU Massive Transfusion

       NICU Pulmonary Hemorrhage

       NICU Alteplase for Chest Tube Clearance

 

 

 

 

 

 

          2008 – Present

publications

 

Monk HM, Motsney AJ, Wade KC.  Safety of rotavirus vaccine in the NICU. Pediatrics 2014;133(6):e1555-e1560.

 

George S, Weber D, Kaplan P, Hummel K, Monk HM, Levine MA.  Short Term Safety of Zoledronic Acid in Young Patients with Bone Disorders: An Extensive Institutional Experience. J Clin Endocrin Metab 2015; epub ahead of print.

 

Jensen EA, White AM, Liu P, Yee K, Waber B, Monk HM, Zhang H. Determinants of Severe Metabolic Bone Disease in VLBW Infants with Severe Bronchopulmonary Dysplasia Admitted to a Tertiary Referral Center. Am J Perinatol 2015; epub ahead of print.

 

Wade KC and HM Monk.  New antiviral and antifungal dosing.  Clin Perinatol 2015; 42(1):177-194.

 

Rustico SE, Kelly A, Monk HM, Calabria AC.  Calcitriol treatment in metabolic bone disease of prematurity with elevated parathyroid hormone: a preliminary study.  J Clin Transl Endocrinol 2015; 2(1): 14-20.

 

Gannon AW, Monk HM, Levine MA.  Cinacalcet monotherapy in neonatal severe hyperparathyroidism: a case study and review.  J Clin Endocrinol Metab 2014;99:7-11.

 

McIntyre CM and Monk HM. Medication absorption considerations in patients with postpyloric enteral feeding tubes.  Am J Health-Syst Pharm 2014;71:549-556.

 

 

 

Sullivan KM, Suh S, Monk HM, Chuo J.  Personalized performance feedback reduces narcotic prescription errors in a NICU. BMJ Qual Saf 2013;22:256-262.

 

Abend NS, Gutierrez-Colina AM, Monk HM, Dlugos DJ, Clancy RR.  Levetiracetam for treatment of neonatal seizures.  J Child Neurol 2011; 26(4):465-470.

 

Abend NS, Monk HM, Licht DJ, Dlugos DJ.  Intravenous levetiracetam in critically ill children with status epilepticus or acute repetitive seizures.  Pediatr Crit Care Med 2009; 10(4): 505-510.

 

 

 

 

 

 

 

 

 

 

 

 

 

Selected posters and presentations

 

 

Monk, HM. Neonatal Abstinence Syndrome: Have we learned anything over the past decade? Invited presentation at the national Neonatal Pharmacology Conference, San Diego, CA

April 2017

Franciscovich CD, Monk HM, Ely E. Sedation practices of neonates receiving extracorporeal membrane oxygenation. Poster presentation, ELSO Conference, San Diego, CA

September 2016

Hoffman ML, Monk HM, Rintoul N, Dysart K, James J, Williams S, Connelly J. Characterization of hypertension management strategies in neonates requiring ECMO support. Poster presentation ELSO Conference, San Diego, CA

September 2016

Monk HM. Vaccinations in the NICU: Scientific Evidence and Debunking the Myths. Invited presentation for Division of Neonatology, The Children’s Hospital of Philadelphia, Philadelphia, PA

August 2016

 

Monk HM.  The Synagis debate: RSV risk, revised recommendations and rising cost.  Invited presentation at the national Neonatal Pharmacology Conference, Phoenix, AZ.

 

Monk HM. Considerations for diuretic use and electrolyte supplementation in chronic lung disease. Invited presentation at the national Neonatal Pharmacology Conference, Phoenix, AZ.

 

Waber B, Jensen EA, Liu P, White A, Yee K, Monk HM, Zhang H.  Postnatal corticosteroids and surgical necrotizing enterocolitis increase metabolic bone disease risk in infants with severe bronchopulmonary dysplasia.  Poster presentation at CHOP Research poster days, Philadelphia, PA.  Poster won a clinical research poster award.

 

Zanno A, Ades A, Rintoul N, Collins J, Williams S, Connelly, J, Monk HM.  A Neonate with Disseminated Candidiasis Treated with ECMO

Poster Presentation at the 25th Annual Extracorporeal Life Support Organization Conference, Ann Arbor, MI

 

 

May 2015

 

 

 

May 2015

 

 

February 2015

 

 

 

 

 

 

September 2014

Ebbert RP, Monk HM, Hedrick HL, Rintoul N, Connelly J, Maschhoff K.  2-Year Review of Dexamethasone use in Congenital Diaphragmatic Hernia Patients During ECMO Support.

Poster Presentation at the 25th Annual Extracorporeal Life Support Organization Conference, Ann Arbor, MI

 

George S, Weber D, Monk HM, Hummel K, Kaplan P, Ganesh J, Levine M.  Assessment of adverse events associated with zoledronic acid use in children and young adults with metabolic and genetic bone disease.

Platform Presentation at the American Society for Bone Mineral Research Conference, Houston, TX

 

Rustico SE, Kelly A, Monk HM, Calabria AC. Calcitriol Treatment in Metabolic Bone Disease of Prematurity with Elevated Parathyroid Hormone: A Preliminary Study.

Poster presentation at the 16th International Congress of Endocrinology/The Endocrine Society’s 96th Annual Meeting and Expo, Chicago, IL

 

September 2014

 

 

 

 

 

 

September 2014

 

 

 

 

 

 

June 2014

Monk, HM.  Acid suppression controversies in the neonate

Invited presentation at the national Neonatal Pharmacology Conference, Boston, MA

May 2014

Monk HM. Diuretic use in the neonate, pharmacokinetic considerations and electrolyte supplementation.

Invited presentation at the national Neonatal Pharmacology Conference, Boston, MA

May 2014

Monk, HM.  Acid suppression controversies in the neonate. 

Invited presentation at the national Newborn and Fetus Conference, Washington, DC

November 2013

Monk HM. Diuretic use in the neonate, pharmacokinetic considerations and electrolyte supplementation.

Invited presentation at the national Newborn and Fetus Conference, Washington, DC

November 2013

Monk HM. Hyperinsulinemia and related treatment modalities.

Invited presentation at the Care of the Surgical Neonate Conference, Philadelphia, PA 

Monk, HM.  Sickle cell disease: Management of Complications, Pain and Vaccinations. Invited presentation at Nurse Practitioner Education Days, Children’s Hospital of Philadelphia

May 2013

 

 

April 2013

Monk HM.  Immature Brains and Kidneys and Livers, Oh My! An introduction to neonatal pharmacology. 

Invited presentation at the Care of the Surgical Neonate: Where the Journey Begins conference, Philadelphia, PA

October 2012

Monk HM.  Medico-legal considerations: consent for off label use. 

Invited presentation at the national Neonatal Pharmacology conference, Washington, DC

June 2012

Monk HM.  Management of peri-intubation medications in the neonate

Invited presentation at the national Neonatal Pharmacology conference, Washington, DC

June 2012

Monk HM and Wade KC.  Safety of rotavirus vaccine administration among infants within the newborn/infant intensive care unit. 

Platform presentation at Pediatric Academic Societies Annual Meeting, Boston, MA

May 2012

Hughes R and Monk HEvaluation of heparin prescribing trends and assessment of a heparin dosing schedule in patients during extracorporeal membrane oxygenation. Platform presentation at the 31st Annual Eastern States Conference for Pharmacy Residents and Preceptors, Hershey, PA

May 2012

Monk HMElectrolyte and Trace Element Supplementation in Bone Health.

Bone Health Conference, Philadelphia, PA

September 2011

Monk HMDiuretic use in the neonate, pharmacokinetic considerations and electrolyte supplementation.

Invited presentation at the national Neonatal Pharmacology Conference, San Francisco, CA

June 2011

Monk HM. Optimizing the use of opioids in the NICU. 

Invited presentation at the national Neonatal Pharmacology conference, San Francisco, CA

June 2011

Monk HM.  Management of narcotic withdrawal secondary to short-term and long-term sedation in the NICU. 

Invited presentation at the national Neonatal Pharmacology conference, San Francisco, CA

June 2011

Motsney A and Monk H. Safety of rotavirus vaccine administration in unvaccinated infants within the newborn/infant intensive care unit.

Platform presentation at the 30th Annual Eastern States Conference for Pharmacy Residents and Preceptors, Hershey, PA

May 2011

Betts PA and Monk HM. A retrospective evaluation of causative pathogens and antibiotic prescribing practices in necrotizing enterocolitis.

Platform presentation at the 30th Annual Eastern States Conference for Pharmacy Residents and Preceptors, Hershey, PA

May 2011

Le KM and Monk HMEvaluation of Extended Interval Gentamicin Dosing in the NICU.

Poster presentation at the 29th Annual Eastern States Conference for Pharmacy Residents and Preceptors, Hershey, PA

May 2010

Monk HM. Pediatric Seizure Disorders.
Invited presentation at the Nurse Practitioner Continuing Education Days, Philadelphia, PA

January 2010

Monk HM. Sickle Cell Disease. 

Invited presentation at the Touching the Future of Children nursing conference, Harrisburg, PA

November 2009

Monk HM and Abend NS. Treatment of children with status epilepticus: development of an emergency department algorithm.  Poster presentation at the 28th Annual Eastern States Conference for Pharmacy Residents and Preceptors, Hershey, PA

May 2009

Monk HM, O’Neill S, Erush S.  Optimization of gentamicin dosing in neonates. 

Platform presentation at the 27th Annual Eastern States Conference for Pharmacy Residents and Preceptors, Hershey, PA

May 2008

 

 

 

 

 

 

 

 

 

 

Honors and awards

 

 

 

 

 

Associations Advance Tennessee Award

via the Pediatric Pharmacy Advocacy Group (PPAG)

From the Tennessee Society of Association Executives for the Artemis Pediatric Initiative.

 

2012

 

Program Consultant

Neonatal Pharmacology

National Conference

2012—Present

 

 

Reviewer for Peer Reviewed Journals

Vaccine

Pediatric Infectious Disease Journal

Journal of Pediatrics

Journal of Addiction Medicine

 

 

 

2013—Present

community service

 

 

Alex’s Lemonade Stand

 

 

2013 – Present

 

 

Landstuhl Hospital Care Project

2007 – Present

 

American Red Cross

2007 – Present

 

Daughters of the American Revolution Veteran Projects

2006 – Present

community memberships

 

St. Mark’s Episcopal Church

2011 – Present

 

references

 

 

Available upon request

 

 

Page 1 of 8